Abstract
The ultimate consequence of horizontal, or lateral, gene transfer, as it is usually understood, is the transient or permanent acquisition by the recipient cell(s) of new, positive or negative, functional characteristics by virtue of the incorporation of the DNA from the donor into their own genome. In reality, it is simply the manifestation of a novel gene expression repertoire(s). It has been recognized for some time that gene expression changes in human cells were primarily the result of structural alterations of their own DNA (mutations, deletions, amplification, or major rearrangements). At present, despite some degree of controversy, it is becoming an increasingly accepted notion that gene expression changes in human cells may be brought about also by their acquisition of exogenous DNA from microorganisms, particularly bacteria, present in the human microbiome. Recent published analyses of information deposited in publicly available data bases of human normal and tumor genome sequences reported a high frequency of detection of bacterial DNA integrated in the human DNA, thus providing solid evidence in support for bacteria-to-human lateral gene transfer. In addition, and most importantly, these studies also showed a much more frequent presence of bacterial DNA in human cancer samples (e.g., acute myeloid leukemia, gastric cancers) than in the DNA samples from healthy individuals, raising the possibility that the bacterial sequences might be directly or indirectly involved in the development of cancer, either by encoding protein/enzyme products with pro-carcinogenic activity or by causing epigenetic alterations that ultimately could lead to genomic instability in the host cells and, later, to carcinogenic progression. This chapter will examine the current status and landmark developments in this still growing and highly innovative research field, focusing on the role of resident bacteria in the onset and/or progression of human gastrointestinal malignancies. We will also discuss the exciting possibility of exploiting bacteria-to-human lateral gene transfer to deliver anticancer therapeutic tools to human tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10:131–144
Abreu MT, Peek RM (2014) Gastrointestinal malignancy and the microbiome. Gastroenterology 146:1534–1546
Aggarwala V et al (2017) Viral communities of the human gut: metagenomic analysis of composition and dynamics. Mob DNA 8:12
Alexander JL et al (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14:356–365
Allen JM et al (2018) Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc 50:747–757
Arends MJ (2013) Pathways of colorectal carcinogenesis. Appl Immunohistochem Mol Morphol 21:97–102
Azzouz D et al (2019) Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis:annrheumdis-2018-214856
Baba Y et al (2017) Review of the gut microbiome and esophageal cancer: pathogenesis and potential clinical implications. Ann Gastroenterol Surg 1:99–104
Baban CK et al (2010) Bacteria as vectors for gene therapy of cancer. Bioeng Bugs 1:6
Baek MK (2010) Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells. Cancer Lett 290:123–128
Behsen J et al (2013) Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med 3:a010074
Beiko RG et al (2005) Highways of gene sharing in prokaryotes. Proc Natl Acad Sci U S A 102:14332–14337
Benard A et al (2013) Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer 109:3073–3083
Bezine E et al (2014) The cytolethal distending toxin effects on Mammalian cells: a DNA damage perspective. Cell 3:592–615
Bhatt AP et al (2017) The role of the microbiome in cancer development and therapy. CA Cancer J Clin 67:326–344
Bierne H, Cossart P (2012) When bacteria target the nucleus: the emerging family of nucleomodulins. Cell Microbiol 14:622–633
Bierne H et al (2012) Epigenetics and bacterial infections. Cold Spring Harb Perspect Med 2:a010272
Biteen JS et al (2016) Tools for the microbiome: nano and beyond. ACS Nano 10:6–37
Bitto NJ et al (2017) Bacterial membrane vesicles transport their DNA cargo into host cells. Sci Rep 7:7072
Blaser MJ, Kirshner D (2007) The equilibria that allow bacterial persistence in human hosts. Nature 449:843–849
Boto L (2014) Horizontal gene transfer in the acquisition of novel traits by metazoans. Proc Biol Sci 281:20132450
Brawner KM et al (2014) Gastric microbiome and gastric cancer. Cancer J 20:211–216
Bullman S et al (2017) Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358:1443–1448
Bultman SJ (2014) Emerging roles of the microbiome in cancer. Carcinogenesis 35:249–255
Burns MB, Blekhman R (2018) Integrating tumor genomics into studies of the microbiome in colorectal cancer. Gut Microbes:1–6. https://doi.org/10.1080/19490976.2018.1549421
Burns MB et al (2018) Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment. PLoS Genet 14:e1007376
Cancer Facts and Figures (2018) American Cancer Society. Atlanta
Cani PD (2018) Human gut microbiome: hopes, threats and promises. Gut 67:1716–1725
Carding S et al (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26:26191
Cario E (2013) Microbiota and innate immunity in intestinal inflammation and neoplasia. Curr Opin Gastroenterol 29:85–91
Castellarin M et al (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–306
Celec P, Gardlik R (2017) Gene therapy using bacterial vectors. Front Biosci 22:81–95
Cervantes-Barragán L et al (2017) Lactobacillus reuteri induces gut intraepithelial CD4+ CD8αα+ T cells. Science 357:806–810
Chen Y et al (2014) Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers 6:2155–2186
Chen Y et al (2017) Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Oncotarget 8:31802–31814
Cheung SG et al (2019) Systematic review of gut microbiota and major depression. Front Psych 10:34
Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13:260–270
Choi IJ et al (2018) Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 378:1085–1095
Chou S et al (2015) Transferred interbacterial antagonism genes augment eukaryotic innate immune function. Nature 518:98–101
Chroscinski D et al (2014) Registered report: melanoma genome sequencing reveals frequent PREX2 mutations. elife 3:e04180. https://doi.org/10.7554/eLife.04180
Chung H et al (2012) Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149:1578–1593
Citi S (2018) Intestinal barriers protect against disease. Science 359:1097–1098
Claesson MJ et al (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108(1):4586–4591
Cohen NA, Maharshak N (2017) Novel indications for fecal microbial transplantation: update and review of the literature. Dig Dis Sci 62:1131–1145
Cohen LJ et al (2017) Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 549:48–53
Corning D et al (2018) The esophageal microbiome in health and disease. Curr Gastroenterol Rep 20:39
Couturier-Maillard A et al (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123:700–711
Crisp A et al (2015) Expression of multiple horizontally acquired genes is a hallmark of both vertebrate and invertebrate genomes. Genome Biol 16:50
Cui J et al (2015) Comprehensive characterization of the genomic alterations in human gastric cancer. Int J Cancer 137:86–95
Cui M et al (2016) Circadian rhythm shapes the gut microbiota affecting host radiosensitivity. Int J Mol Sci 17:E1786
Cui M et al (2017) Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med 9:448–461
Dahmus JD et al (2018) The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol 9:769–777
Das A et al (2016) Xenobiotic metabolism and gut microbiomes. PLoS One 11:e0163099
Dejea CM et al (2018) Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359:592–597
Desphande NP et al (2018) Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome 6:227
Di Pilato V et al (2016) The esophageal microbiota in health and disease. Ann N Y Acad Sci 1381:21–33
Ding SZ et al (2010) Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One 5:e9875
Ding C et al (2018) Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther 11:4797–4810
Dominguez Bello MG et al (2018) Preserving microbial diversity. Science 362:33–34
Dominguez-Bello MG et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107:11971–11975
Donaldson GP et al (2018) Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360:795–800
Doran KS et al (2013) Concepts and mechanisms: crossing host barriers. Cold Spring Harb Perspect Med 3:a010090
Duning Hotopp JC et al (2007) Widespread lateral gene transfer from intracellular bacteria to multicellular eukaryotes. Science 317:1753–1756
Dunning Hotopp JC (2011) Horizontal gene transfer between bacteria and animals. Trends Genet 27:157–163
Dunning Hotopp JC (2018) Grafting or pruning in the animal tree: lateral gene transfer and gene loss? BMC Genomics 19:470
Dziki L et al (2017) Modulation of colorectal cancer risk by polymorphisms in 51Gln/His, 64Ile/Val, and 148Asp/Glu of APEX gene; 23Gly/Ala of XPA gene; and 689Ser/Arg of ERCC4 gene. Gastroenterol Res Pract 2017:3840243
Faith JJ et al (2013) The long-term stability of the human gut microbiota. Science 341:1237439
Falony G et al (2016) Population-level analysis of gut microbiome variation. Science 352:560–564
Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479–507
Fernández MF et al (2018) Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health 15:E1747. https://doi.org/10.3390/ijerph15081747
Fine B et al (2009) Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325:1261–1265
Fischbach MA (2018) Microbiome: focus on causation and mechanism. Cell 174:785–790
Flemer B et al (2017) Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 66:633–643
Flint HJ et al (2017) The impact of nutrition on intestinal bacterial communities. Curr Opin Microbiol 38:59–65
Foster JA et al (2012) Measuring the microbiome: perspectives on advances in DNA-based techniques for exploring microbial life. Brief Bioinform 13:420–429
Frank DN et al (2007) Molecular–phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780–13785
Fulbright LE et al (2017) The microbiome and the hallmarks of cancer. PLoS Pathog 13:e1006480
Gevers D et al (2014) The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15:382–392
Gilbert JA et al (2018) Current understanding of the human microbiome. Nat Med 24:392–400
Goel A, Boland CR (2012) Epigenetics of colorectal cancer. Gastroenterology 143:1442–1460
Golombos DM et al (2018) The role of gut microbiome in the pathogenesis of prostate Cancer: a prospective, pilot study. Urology 111:122–128
González-SarrÃas A (2010) NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br J Nutr 104:503–512
Goodman B, Gardner H (2018) The microbiome and cancer. J Pathol 244:667–676
Goodrich GM et al (2014) Conducting a microbiome study. Cell 158:250–262
Gopalakrishnan V et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359:97–103
Goubet AG et al (2018) The impact of the intestinal microbiota in therapeutic responses against cancer. C R Biol 341:284–289
Graillot V et al (2016) Genotoxicity of cytolethal distending toxin (CDT) on isogenic human colorectal cell lines: potential promoting effects for colorectal carcinogenesis. Front Cell Infect Microbiol 6:34
Greathouse KL et al (2018) Interaction between the microbiome and TP53 in human lung cancer. Genome Biol 19:123
Groth AC et al (2000) A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci U S A 97:5995–6000
Hagland HR, Søreide K (2015) Cellular metabolism in colorectal carcinogenesis: influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett 356:273–280
Hancks DC, Kazazian HH (2012) Active human retrotransposons: variation and disease. Curr Opin Genet Dev 22:191–203
He S et al (2016) Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling. Oncol Lett 11:2223–2228
Hemminki K, Boffetta P (2004) Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 157:289–297
Hodgetts T et al (2018) The microbiome and its publics: a participatory approach for engaging publics with the microbiome and its implications for health and hygiene. EMBO Rep 19:e45786
Huang W et al (2017) Widespread of horizontal gene transfer in the human genome. BMC Genomics 18:274
Huerta-Cepas J et al (2007) The human phylome. Genome Biol 8:R109
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1–441
Jiang H et al (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48:186–194
Jin C et al (2019) Commensal microbiota promote lung cancer development via γδT cells. Cell 176:998–1013
Jobin C (2018) Precision medicine using microbiota. Science 359:32–34
Johnson et al (2015) Prebiotics modulate the effects of antibiotics on gut microbial diversity and functioning in vitro. Nutrients 7:4480–4497
Jones RB et al (2018) Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples. Sci Rep 8:4139
Kaakush NO (2018) Microbiome and esophageal adenocarcinoma. Cancer Res 78:1574
Kelly D, Mulder IE (2012) Microbiome and immunological interactions. Nutr Rev 70(1):S18–S30
Kelly DL et al (2016) The microbiome and cancer: implications for oncology nursing science. Cancer Nurs 39:E56–E62
Kesselring R et al (2016) IRAK-M expression in tumor cells supports colorectal cancer progression through reduction of antimicrobial defense and stabilization of STAT3. Cancer Cell 29:684–696
Kikuchi S (2002) Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 5:6–15
Kim E et al (2016) Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk. Cell Death Dis 7:e2460
Kim W-J et al (2018) Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells. J Biol Chem 293:16518–16527
Koga T et al (2002) Experimental Helicobacter pylori gastric infection in miniature pigs. J Med Microbiol 51:238–246
Kominek J et al (2019) Eukaryotic acquisition of a bacterial operon. Cell 176:1356–1366
Koppel N et al (2017) Chemical transformation of xenobiotics by the human gut microbiota. Science 356:eaag2770
Kostic AD et al (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22:292–298
Kostic AD et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14:207–215
Kowarsky M et al (2017) Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA. Proc Natl Acad Sci U S A 114:9623–9628
Krautkramer KA et al (2016) Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 64:982–992
Kroemer G, Zitvogel L (2018) Cancer immunotherapy in 2017: the breakthrough of the microbiota. Nat Rev Immunol 18:87–88
Kumar H et al (2014) Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 5:e02113–e02114
Lacroix B, Citovsky V (2016) Transfer of DNA from bacteria to eukaryotes. MBio 7:e00863–e00816
Lander ES, International Human Genome Sequencing Consortium et al (2001) Initial sequencing and analysis of human genome. Nature 409:860–921
Lee E-S et al (2017) Dysbiosis of gut microbiome and its impact on epigenetic regulation. J Clin Epigenetics 3:14
Lemichez E, Barbieri JT (2013) General aspects and recent advances on bacterial protein toxins. Cold Spring Harb Perspect Med 3:a013573
Lerner A et al (2017) Transglutaminases in dysbiosis as potential environmental drivers of autoimmunity. Front Microbiol 8:66
Lichtenstein P et al (2000) Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Lissanu Deribe Y (2016) Mechanistic insights into the role of truncating PREX2 mutations in melanoma. Mol Cell Oncol 3:e1160174
Liu W et al (2016) Merkel cell polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol 20:20–27
Llosa M et al (2012) New perspectives into bacterial DNA transfer to human cells. Trends Microbiol 20:355–359
Louis P et al (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661–672
Lu R et al (2017) Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens. Oncotarget 8:55104–55115
Luckey TD (1972) Introduction to intestinal microecology. Am J Clin Nutr 25:1292–1294
Ma C et al (2018) Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360(6391):eaan5931
Maier L et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628
Maisonneuve C et al (2018) The impact of the gut microbiome on colorectal cancer. Annu Rev Cancer Biol 2:229–249
Malinowski B et al (2019) The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infect Agent Cancer 14:3
Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315
Maruvada P et al (2017) The human microbiome and obesity: moving beyond associations. Cell Host Microbe 22:589–599
Matson V et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359:104–108
McCoy AN et al (2013) Fusobacterium is associated with colorectal adenomas. PLoS One 8:e53653
Metcalf JA et al (2014) Antibacterial gene transfer across the tree of life. elife 3:e04266. https://doi.org/10.7554/eLife.04266
Mira-Pascual L et al (2015) Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 50:167–179
Mitarai N et al (2016) Population dynamics of phage and bacteria in spatially structured habitats using phage λ and Escherichia coli. J Bacteriol 198:1783–1793
Mohanan V et al (2018) C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 359:1161–1166
Moosavi S (2014) Location-specific effect of microbiota and MyD88-dependent signaling on Wnt/β-catenin pathway and intestinal stem cells. Gut Microbes 5:11–14
Moreira D, Lopez-Garcia P (2017) Protist evolution: stealing genes to gut it out. Curr Biol 27:R223–R225
Morishita Y, Shimizu T (1983) Promoting effect of intestinal Pseudomonas aeruginosa on gastric tumorigenesis in rats with N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Lett 17:347–352
Moss SF (2017) The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol 3:183–191
Mughini-Gras L et al (2018) Increased colon cancer risk after severe Salmonella infection. PLoS One 13:e0189721
Munro MJ et al (2018) Cancer stem cells in colorectal cancer: a review. J Clin Pathol 71:110–116
Naito T et al (2017) Lipopolysaccharide from crypt-specific core microbiota modulates the colonic epithelial proliferation-to-differentiation balance. MBio 8:e01680–e01617
Nakata K et al (2017) Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem 292:15426–15433
Nardone G, Compare D (2015) The human gastric microbiota: is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol J 3:255–260
Narihiro T, Kanagata Y (2017) Genomics and metagenomics in microbial ecology: recent advances and challenges. Microbes Environ 32:1–4
Navarro F, Muniesa M (2017) Phages in the human body. Front Microbiol 8:566
Nguyen S et al (2017) Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. MBio 8:e01874–e01817
Ni J et al (2017) A role for bacterial urease in gut dysbiosis and Crohn’s disease. Sci Transl Med 9:eaah6888
Niederreiter L et al (2018) Food, microbiome and colorectal cancer. Dig Liver Dis 50:647–652
Nistal E et al (2015) Factors determining colorectal cancer: the role of the intestinal microbiota. Front Oncol 5:220
Noto JM, Peek RM (2017) The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog 13:e1006573
O’Connell Motherway M et al (2019) A Bifidobacterial pilus-associated protein promotes colonic epithelial proliferation. Mol Microbiol 111:287–301
Ochman H et al (2000) Lateral gene transfer and the nature of bacterial innovation. Nature 405:299–304
Park SY et al (2009) Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol 219:410–416
Paul B et al (2015) Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics 7:112
Perduca V et al (2018) Mutational and epigenetic signatures in cancer tissue linked to environmental exposures and lifestyle. Curr Opin Oncol 30:61–67
Peters BA et al (2017) Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res 77:6777–6787
Porayath C et al (2018) Characterization of the bacteriophages binding to human matrix molecules. Int J Biol Macromol 110:608–615
Raza MH et al (2019) Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 45:49–63
Reticker-Flynn NE, Engleman EG (2019) A gut punch fights cancer and infection. Nature 565:573–574
Riley DR et al (2013) Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol 9:e1003107
Robinson KM, Dunning Hotopp JC (2014) Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen. Cancer Lett 352:137–144
Robinson KM et al (2013) A review of bacteria-animal lateral gene transfer may inform our understanding of diseases like cancer. PLoS Genet 9:e1003877
Rosadi F et al (2016) Bacterial protein toxins in human cancers. Pathog Dis 74:ftv105
Rosner JL (2014) Ten times more microbial cells than body cells in humans? Microbe 9:47
Routy B et al (2018a) The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 15:382–396
Routy B et al (2018b) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91–97
Roy S, Trinchieri G (2017) Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 17:271–285
Rubinstein MR et al (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206
Salzberg SL (2017) Horizontal gene transfer is not a hallmark of the human genome. Genome Biol 18:85
Salzberg SL et al (2001) Microbial gene in the human genome: lateral transfer or gene loss? Science 292:1903–1906
Savidge TC (2016) Epigenetic regulation of enteric neurotransmission by gut bacteria. Front Cell Neurosci 9:503
Schmidt TSB et al (2018) The human gut microbiome: from association to modulation. Cell 172:1198–1215
Schwarzenbach H et al (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426–437
Sekirov I et al (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Sender R et al (2016a) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164:337–340
Sender R et al (2016b) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533
Shan J et al (2018) Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells. Sci Rep 8:5091
Sieber KB et al (2016) Modeling the integration of bacterial rRNA fragments into the human cancer genome. BMC Bioinf 17:134
Sieber KB et al (2017) Lateral gene transfer between prokaryotes and eukaryotes. Exp Cell Res 358:421–426
Siegel RL et al (2017) Colorectal cancer mortality rates in adults aged 20 to 54 years in the United States, 1970-2014. JAMA 318:572–574
Siegel RL et al (2018) Cancer statistics. CA Cancer J Clin 68:7–30
Sivaprakasam S et al (2017) Cell-surface and nuclear receptors in the colon as targets for bacterial metabolites and its relevance to colon health. Nutrients 9:E856
Snider EJ et al (2018) Barrett’s esophagus is associated with a distinct oral microbiome. Clin Transl Gastroenterol 9:135
Solyom S et al (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22:2328–2338
Song EJ et al (2018) Progress of analytical tools and techniques for human gut microbiome research. J Microbiol 10:693–705
Stecher B et al (2012) Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 109:1269–1274
Strandwitz P et al (2019) GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 4:396–403
Sun J (2010) Enteric bacteria and cancer stem cells. Cancers 3:285–297
Sun J, Kato I (2016) Gut microbiota, inflammation and colorectal cancer. Genes Dis 3:130–143
Suzuki K et al (2015) Horizontal DNA transfer from bacteria to eukaryotes and a lesson from experimental transfers. Res Microbiol 166:753–763
Tanoue T et al (2019) A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565:600–605
Tetz G, Tetz V (2018) Bacteriophages as new human viral pathogens. Microorganisms 6:E54
Thierry AR et al (2016) Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 35:347–376
Tilg H et al (2018) The intestinal microbiota in colorectal cancer. Cancer Cell 33:954–964
Touchefeu Y et al (2014) Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis: current evidence and potential clinical applications. Aliment Pharmacol Ther 40:409–421
Toyofuku M et al (2019) Types and origins of bacterial membrane vesicles. Nat Rev Microbiol 17:13–24
Tuan J, Chen Y-X (2016) Dietary and lifestyle factors associated with colorectal cancer risk and interactions with microbiota: Fiber, red or processed meat and alcoholic drinks. Gastrointest Tumors 3:17–24
Turnbaugh P et al (2007) The human microbiome project. Nature 449:804–810
Vakil N, Megraud F (2007) Eradication therapy for Helicobacter pylori. Gastroenterology 133:985–1001
van Elsland D, Neefjes J (2018) Bacterial infections and cancer. EMBO Rep 19:e46632
Venturelli OS et al (2018) Deciphering microbial interactions in synthetic human gut microbiome communities. Mol Syst Biol 14:e8157
Vieira M et al (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156–1161
Wang Y et al (2017) The intestinal microbiota regulates body composition through NFIL3 and the circadian clock. Science 357:912–916
Wegmann U et al (2017) Use of genetically modified bacteria for drug delivery in humans: revisiting the safety aspect. Sci Rep 7:2294
Weinstock GM (2012) Genomic approaches to studying the human microbiota. Nature 489:250–256
Wenger SL et al (1981) Incorporation of bacteriophage DNA into the genome of cultured human lymphocytes. In Vitro 17:695–700
Werawatganon D (2014) Simple animal model of Helicobacter pylori infection. World J Gastroenterol 20:6420–6424
White MK et al (2014) Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev 27:463–481
Wilson MR et al (2019) The human gut bacterial genotoxin colibactin alkylates DNA. Science 363:eaar7785
Wroblewski LE et al (2016) The role of the microbiome in gastrointestinal cancer. Gastroenterol Clin N Am 45:543–556
Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461–488
Wu S et al (2018a) Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun 9:3490
Wu X et al (2018b) Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer 9:2510–2517
Xiao HW et al (2018) Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88’s effects on the gut microbiota. Exp Mol Med 50:e433
Xu J et al (2017) Emerging trends in microbiome analysis: from single-cell functional imaging to microbiome. Engineering 3:66–70
Yang T et al (2013) Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med 19:714–725
Yang L et al (2014) Microbiome in reflux disorders and esophageal adenocarcinoma. Cancer J 20:207–210
Yang J et al (2016) PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway. Oncol Lett 12:1139–1143
Yang Y et al (2017) Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21. Gastroenterology 152:851–866
Yilmaz B et al (2019) Microbial network disturbances in relapsing refractory Crohn’s disease. Nat Med 25:323–336
Yu YN et al (2015) Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget 6:32013–32026
Yu G et al (2017a) Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol 7:302
Yu T et al (2017b) Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170:548–563
Zackular JP et al (2014) The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res 7:1112–1121
Zheng P et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21:786–796
Zierer J et al (2018) The fecal metabolome as a functional readout of the gut microbiome. Nat Genet 50:790–795
Zitvogel L (2016) Microbiome and anticancer immunosurveillance. Cell 165:276–287
Zitvogel L et al (2017) Anticancer effects of the microbiome and its products. Nat Rev Microbiol 15:465–478
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Abril, A.G., Lanzi, P.G., Notario, V. (2019). Implications of Lateral or Horizontal Gene Transfer from Bacteria to the Human Gastrointestinal System for Cancer Development and Treatment. In: Villa, T., Viñas, M. (eds) Horizontal Gene Transfer. Springer, Cham. https://doi.org/10.1007/978-3-030-21862-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-21862-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21861-4
Online ISBN: 978-3-030-21862-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)